Literature DB >> 30283276

Genotyping in Sickle Cell Disease Patients: The French Strategy.

Aline Floch1,2,3,4, Christophe Tournamille1,2,3, Btissam Chami1, France Pirenne1,2,3,4.   

Abstract

This review presents the French strategy for blood group genotyping in high-responder and newly diagnosed sickle cell disease (SCD) patients. In addition to FY, JK, and MNS genotyping, the RH blood group system is now explored in SCD patients in France. Molecular typing has been used for the deduction of partial RH2 (C) antigens since 2010, and the gradual implementation of systematic RHD and RHCE genotyping nationwide was initiated in late 2014. In our laboratory, 962 RH:2 (C-positive) SCD patients have been tested since 2010, and 1,148 SCD patients of all RH phenotypes have been genotyped for clinically relevant alleles of RHD and RHCE since late 2014.

Entities:  

Keywords:  Blood group genotyping; Partial antigens; RH antigens; Sickle cell disease; Transfusion medicine

Year:  2018        PMID： 30283276      PMCID： PMC6158580          DOI： 10.1159/000490858

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


  45 in total

1.  Weak D alleles express distinct phenotypes.

Authors:  F F Wagner; A Frohmajer; B Ladewig; N I Eicher; C B Lonicer; T H Müller; M H Siegel; W A Flegel
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

2.  Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.

Authors:  France Noizat-Pirenne; Ketty Lee; Pierre-Yves Le Pennec; Philippe Simon; Philippe Kazup; Dora Bachir; Anne-Marie Rouzaud; Michele Roussel; Geneviève Juszczak; Cècile Ménanteau; Philippe Rouger; Rami Kotb; Jean-Pierre Cartron; Hélène Ansart-Pirenne
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

Review 3.  Relevance of RH variants in transfusion of sickle cell patients.

Authors:  F Noizat-Pirenne; C Tournamille
Journal:  Transfus Clin Biol       Date:  2011-10-22       Impact factor: 1.406

4.  Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.

Authors:  Ross M Fasano; Garrett S Booth; Megan Miles; Liping Du; Tatsuki Koyama; Emily Riehm Meier; Naomi L C Luban
Journal:  Br J Haematol       Date:  2014-09-26       Impact factor: 6.998

5.  A serologic study of red cells and sera from 18 Rh:32,-46 (RN/RN) persons.

Authors:  P Y Le Pennec; P Rouger; M T Klein; M Kornprobst; Y Brossard; B Boizard; C Salmon
Journal:  Transfusion       Date:  1989 Nov-Dec       Impact factor: 3.157

6.  Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype.

Authors:  Monique Silvy; Christophe Tournamille; Jérôme Babinet; Sadaf Pakdaman; Sylvain Cohen; Jacques Chiaroni; Frédéric Galactéros; Philippe Bierling; Pascal Bailly; France Noizat-Pirenne
Journal:  Haematologica       Date:  2014-04-11       Impact factor: 9.941

7.  Delayed hemolytic transfusion reaction in children with sickle cell disease.

Authors:  Mariane de Montalembert; Marie-Dominique Dumont; Claire Heilbronner; Valentine Brousse; Oussama Charrara; Béatrice Pellegrino; Christophe Piguet; Valérie Soussan; France Noizat-Pirenne
Journal:  Haematologica       Date:  2011-02-17       Impact factor: 9.941

8.  Molecular background of RH in Bastiaan, the RH:-31,-34 index case, and two novel RHD alleles.

Authors:  M E Reid; C H Hipsky; R W Velliquette; C Lomas-Francis; K Larimore; C Olsen
Journal:  Immunohematology       Date:  2012

9.  Transfusion strategy for weak D Type 4.0 based on RHD alleles and RH haplotypes in Tunisia.

Authors:  Mouna Ouchari; Kshitij Srivastava; Houda Romdhane; Saloua Jemni Yacoub; Willy Albert Flegel
Journal:  Transfusion       Date:  2017-11-29       Impact factor: 3.157

10.  Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia.

Authors:  Stella T Chou; Jonathan M Flanagan; Sunitha Vege; Naomi L C Luban; R Clark Brown; Russell E Ware; Connie M Westhoff
Journal:  Blood Adv       Date:  2017-08-03
View more
  3 in total

Review 1.  How to avoid the problem of erythrocyte alloimmunization in sickle cell disease.

Authors:  France Pirenne; Aline Floch; Anoosha Habibi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  Towards a Regional Registry of Extended Typed Blood Donors: Molecular Typing for Blood Group, Platelet and Granulocyte Antigens.

Authors:  Jan Portegys; Gabi Rink; Pia Bloos; Erwin A Scharberg; Harald Klüter; Peter Bugert
Journal:  Transfus Med Hemother       Date:  2018-09-24       Impact factor: 3.747

3.  It's time to phase out "serologic weak D phenotype" and resolve D types with RHD genotyping including weak D type 4.

Authors:  Willy A Flegel; Gregory A Denomme; John T Queenan; Susan T Johnson; Margaret A Keller; Connie M Westhoff; Louis M Katz; Meghan Delaney; Ralph R Vassallo; Clayton D Simon; S Gerald Sandler
Journal:  Transfusion       Date:  2020-03-12       Impact factor: 3.337
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.